Dsk2 Antibody (C-term) Blocking Peptide

Dsk2 Antibody (C-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP2175b
Catalog Number: AC-BP2175b
Size: 500 µg
Datasheet
Request Information
Background:
Dsk2 increases the half-life of proteins destined to be degraded by the proteasome, and may modulate proteasome-mediated protein degradation. The Dsk2 protein binds UBE3A and BTRC, and interacts with the 19S proteasome subunit. In the cytoplasm, Dsk2 colocalizes with the proteasome; it is also associated with fibers in mitotic cells in the nucleus. Dsk2 is highly expressed in mitotic cells from metaphase to telophase, while expression in non-mitotic cells is very low.

Other Names:
Ubiquilin-2, Chap1, DSK2 homolog, Protein linking IAP with cytoskeleton 2, PLIC-2, hPLIC-2, Ubiquitin-like product Chap1/Dsk2, UBQLN2, N4BP4, PLIC2

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2175b was selected from the C-term region of human Dsk2 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: UBQLN2

Gene ID: 29978
Primary Accession: Q9UHD9
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:Dsk2 Antibody (C-term) Blocking Peptide